Heribert Staudinger

12.3k citations

78 papers · 2.7k indexed · 3 hit papers · h-index 25

Impact in

Immunology and Allergy top 0.2%
- Allergic Rhinitis and Sensitization
Otorhinolaryngology top 0.5%
- Sinusitis and nasal conditions

Papers in

Immunology and Allergy 23
- Allergic Rhinitis and Sensitization 23
Otorhinolaryngology 15
- Sinusitis and nasal conditions 15

Co-authors: Claus Bachert Eli O. Meltzer Neil M.H. Graham Nikhil Amin Philippe Gevaert Paul Stryszak Gianluca Pirozzi Bolanle Akinlade
Journals: Journal of Allergy and Clinical Immunology (15 papers)Annals of Allergy Asthma & Immunology (5 papers)Allergy (3 papers)Respiratory Research (2 papers)Current Medical Research and Opinion (2 papers)
Partner nations: United States France Germany

In The Last Decade

Heribert Staudinger

76 papers receiving 2.6k citations

Hit Papers

align trajectories log scale

Dupilumab in patients with chronic spontaneous urticaria (LIBERTY-CSU CUPID): Two randomized, double-blind, placebo-controlled, phase 3 trials 2024 · 65 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2024 Journal of Allergy and Clinical Immunology
2023 Nature Medicine
2019 British Journal of Dermatology

Peers

Countries citing papers authored by Heribert Staudinger

Since Specialization

Citations

This map shows the geographic impact of Heribert Staudinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heribert Staudinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heribert Staudinger more than expected).

Fields of papers citing papers by Heribert Staudinger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heribert Staudinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heribert Staudinger. The network helps show where Heribert Staudinger may publish in the future.

Co-authors

The 25 scholars most cited alongside Heribert Staudinger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Heribert Staudinger Line = papers co-authored together Heribert Staudinger links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	A Randomized Phase I Trial Evaluating Safety and Pharmacokinetics of Single and Multiple Ascending Doses of Eclitasertib, a RIPK1 Inhibitor, in Healthy Participants Advances in Therapy ·Viljami Lyytikainen, Sandy Garcon, Salvatore Badalamenti, Annie J. Kruger, Robert J. Pomponio, Tillmann Krahnke, Heribert Staudinger, Yong Lin	2025	1
2	Blood eosinophils and fractional exhaled nitric oxide are prognostic and predictive biomarkers in childhood asthma Journal of Allergy and Clinical Immunology ·Leonard B. Bacharier, Ian Pavord, Jorge Máspero, Daniel J. Jackson, Alessandro Fiocchi, วันชัย วรวัฒนเมธีกุล, Juby A. Jacob‐Nara, Yamo Deniz, Elizabeth Laws, Leda Mannent, Nikhil Amin, Bolanle Akinlade, Heribert Staudinger, David J. Lederer, Megan Hardin	2024	23
3	A first‐in‐human, single and multiple dose study of lunsekimig, a novel anti‐TSLP/anti‐IL‐13 NANOBODY® compound, in healthy volunteers Clinical and Translational Science ·Annemie Deiteren, Michelle Mates, Griet Conickx, Marie Vigan, M Epner, حنافي حاج, Yousif Obaid, Benjamin T. Suratt, Heribert Staudinger, 周碧娥	2024	17
4	Dupilumab in patients with chronic spontaneous urticaria (LIBERTY-CSU CUPID): Two randomized, double-blind, placebo-controlled, phase 3 trials Journal of Allergy and Clinical Immunology ·Marcus Maurer, Thomas B. Casale, Sarbjit S. Saini, Moshe Ben‐Shoshan, Ana M. Giménez‐Arnau, Jonathan A. Bernstein, Akiko Yagami, S. Bave, Allen Radin, Heribert Staudinger, Naimish Patel, Nikhil Amin, Bolanle Akinlade, Chunpeng Fan, Déborah Bauer, George D. Yancopoulos, Kiran Patel, Leda Mannent, Elizabeth Laws Hit paper breakdown →	2024	65
5	Immunomodulatory and clinical effects of receptor-interacting protein kinase 1 (RIPK1) inhibitor eclitasertib (SAR443122) in patients with severe COVID-19: a phase 1b, randomized, double-blinded, placebo-controlled study Respiratory Research ·Sandy Garcon, Viljami Lyytikainen, Benjamin T. Suratt, Tillmann Krahnke, 山下達也, Peter Florian, Robert J. Pomponio, Naimish Patel, Maria Wiekowski, Yong Lin, Benjamin Terrier, Heribert Staudinger	2024	12
6	Elevated fractional exhaled nitric oxide is prevalent in those with mild-to-moderate asthma with self-reported asthma control Annemie Deiteren, M Epner, Αθανάσιος Χριστοφορίδης, Jason H. Maley, Naimish Patel, Yousif Obaid, Heribert Staudinger, Benjamin T. Suratt	2024	0
7	Dupilumab in patients with prurigo nodularis: two randomized, double-blind, placebo-controlled phase 3 trials Nature Medicine ·Gil Yosipovitch, Nicholas Mollanazar, Sonja Ständer, Shawn G. Kwatra, Brian Kim, Elizabeth Laws, Leda Mannent, Nikhil Amin, Bolanle Akinlade, Heribert Staudinger, Naimish Patel, George D. Yancopoulos, David M. Weinreich, Sheldon Wang, Genming Shi, Ashish Bansal, John T. O’Malley Hit paper breakdown →	2023	119
8	Dupilumab improves upper and lower airway disease control in chronic rhinosinusitis with nasal polyps and asthma Annals of Allergy Asthma & Immunology ·Tanya M. Laidlaw, Claus Bachert, Nikhil Amin, Martin Desrosiers, Peter W. Hellings, Joaquim Mullol, Jorge Máspero, Philippe Gevaert, Mei Zhang, วันชัย วรวัฒนเมธีกุล, Asif Khan, Siddhesh Kamat, Naimish Patel, Neil M.H. Graham, Marcella Ruddy, Heribert Staudinger, Leda Mannent	2021	75
9	Dupilumab improves health‐related quality of life in patients with chronic rhinosinusitis with nasal polyposis Allergy ·Claus Bachert, Peter W. Hellings, Joaquim Mullol, Daniel L. Hamilos, Philippe Gevaert, Robert M. Naclerio, Vijay N. Joish, Jingdong Chao, Leda Mannent, Nikhil Amin, Adeline Abbé, محمدرضا امیرسیف الدینی, Chunpeng Fan, Gianluca Pirozzi, Neil M.H. Graham, Puneet Mahajan, Heribert Staudinger, Asif Khan	2019	74
10	Dupilumab reduces need for systemic corticosteroid use, sinonasal surgery in patients with severe chronic rhinosinusitis with nasal polyps : pooled results from the SINUS- 24, SINUS- 52 phase 3 studies Allergy ·Martin Desrosiers, Claus Bachert, Peter W. Hellings, C Hopkins, Heidi Olze, 陽子小林, Se Lee, Ramasamy Anitha, Xiang Lu, Nikhil Amin, Naimish Patel, Engin Altıntaş, M. Ruddy, Heribert Staudinger, C. Ochando	2019	4
11	Dupilumab reduces opacification across all sinuses and related symptoms in patients with CRSwNP Rhinology Journal ·Claus Bachert, S. James Zinreich, Peter W. Hellings, Joaquim Mullol, Daniel L. Hamilos, Philippe Gevaert, Robert M. Naclerio, Nikhil Amin, Moretti Jl, Chunpeng Fan, Donghui Zhang, Heribert Staudinger, Gianluca Pirozzi, Neil M.H. Graham, Asif Khan, Leda Mannent	2019	35
12	Efficacy and safety of dupilumab in perennial allergic rhinitis and comorbid asthma Journal of Allergy and Clinical Immunology ·Steven F. Weinstein, Rohit Katial, Shyamalie Jayawardena, Gianluca Pirozzi, Heribert Staudinger, Laurent Eckert, Vijay N. Joish, Nikhil Amin, Jaman Maroni, Paul Rowe, Neil M.H. Graham, Ariel Teper	2018	98
13	251 Treatment interruption did not impact efficacy or long-term safety of dupilumab: A phase 3 open-label trial Journal of Investigative Dermatology ·Lisa A. Beck, Najib Alidrissi, Alesandro, Paula Holland, Heribert Staudinger, Neil M.H. Graham, Gianluca Pirozzi, Marius Ardeleanu	2017	1
14	CXCR2 Antagonist MK-7123. A Phase 2 Proof-of-Concept Trial for Chronic Obstructive Pulmonary Disease American Journal of Respiratory and Critical Care Medicine ·Stephen I. Rennard, David C. Dale, James F. Donohue, Frank Kanniess, H Magnussen, E. Rand Sutherland, Henrik Watz, Susan Lu, Paul Stryszak, Elizabeth Rosenberg, Heribert Staudinger	2015	190
15	Efficacy and safety characteristics of mometasone furoate/formoterol fumarate fixed-dose combination in subjects with moderate to very severe COPD: findings from pooled analysis of two randomized, 52-week placebo-controlled trials SHILAP Revista de lepidopterología ·Chistian O. Dimkpa, 直人竹ヶ鼻, Edward Kerwin, L Pinterová, Barbara Knorr, Tulin Shekar, Campos Cantero R, Heribert Staudinger	2012	2
16	Improved adherence with once-daily versus twice-daily dosing of mometasone furoate administered via a dry powder inhaler: a randomized open-label study BMC Pulmonary Medicine ·David Price, 猪一郎関根, 澤辺悦子, Cynthia S. Rand, Rob Horne, Heribert Staudinger	2010	141
17	One-year treatment with mometasone furoate in chronic obstructive pulmonary disease Respiratory Research ·Peter M.A. Calverley, Stephen I. Rennard, Harold S. Nelson, Jill P. Karpel, Eduardo Abbate, Paul Stryszak, Heribert Staudinger	2008	42
18	Effects of treatment with mometasone furoate dry powder inhaler in children with persistent asthma Annals of Allergy Asthma & Immunology ·袁银芳, Henry Milgrom, Paul Chervinsky, Michael Noonan, Steven F. Weinstein, Barry N. Lutsky, Heribert Staudinger	2006	24
19	A Randomized Controlled Trial of Mometasone Furoate Nasal Spray for the Treatment of Nasal Polyposis Archives of Otolaryngology - Head and Neck Surgery ·Pär Stjärne, Ralph Mösges, Mark Jorissen, Desiderio Passàli, Luisa Bellussi, Heribert Staudinger, Melvyn Danzig	2006	94
20	Safety of desloratadine syrup in children Current Medical Research and Opinion ·Laura Dobkowicz, Heribert Staudinger, Jerry Herron	2004	46

About Heribert Staudinger

Heribert Staudinger is a scholar working on Immunology and Allergy, Otorhinolaryngology, Physiology, Dermatology and Pulmonary and Respiratory Medicine, having authored 78 papers that have together received 2.7k indexed citations. Recurring topics across this work include Asthma and respiratory diseases (57 papers), Allergic Rhinitis and Sensitization (23 papers), Sinusitis and nasal conditions (15 papers), Inhalation and Respiratory Drug Delivery (14 papers), Dermatology and Skin Diseases (14 papers), IL-33, ST2, and ILC Pathways (14 papers), Respiratory and Cough-Related Research (12 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (11 papers). The work is most often cited by research in Immunology and Allergy (1.2k citations), Otorhinolaryngology (791 citations), Physiology (1.6k citations), Dermatology (462 citations) and Pulmonary and Respiratory Medicine (826 citations). Heribert Staudinger has collaborated with scholars based in United States, France and Germany. Frequent co-authors include Claus Bachert, Eli O. Meltzer, Neil M.H. Graham, Nikhil Amin, Philippe Gevaert, Paul Stryszak, Gianluca Pirozzi, Bolanle Akinlade, Melvyn Danzig and Jan Tavernier. Their work appears in journals such as Journal of Allergy and Clinical Immunology, Annals of Allergy Asthma & Immunology, Allergy, Respiratory Research and Current Medical Research and Opinion.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact